How a new long-acting HIV drug combo tackles resistance

A new long-acting HIV treatment could expand options for people who have trouble taking daily pills and whose virus is resistant to some commonly used HIV drugs, according to a new UC San Francisco study.

How a specific protein may drive brain damage in neuroHIV

While powerful medications can suppress the spread of HIV and its progression to AIDS, there are no cures, and many people living with HIV experience nervous system problems. Called neuroHIV, these complications occur when ...

page 1 from 24